Grail Inc
GRAL
NASDAQ
Biotechnology
$67.87
USD
-0.37 (-0.54%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $3.05B
Volume 433.0K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
LEGN | Legend Biotech Corp | $4.00B | - | +56.4% | - | |
IDYA | IDEAYA Biosciences Inc | $3.55B | - | +3118.1% | - | |
CLDX | Celldex Therapeutics Inc | $3.39B | - | -97.3% | - | |
GRAL | Grail Inc | $3.34B | - | +19.4% | - | |
ARQT | Arcutis Biotherapeutics Inc | $3.25B | 114.06 | +76.1% | - | |
IRON | Disc Medicine Inc | $3.01B | - | - | - | |
IOVA | Iovance Biotherapeutics Inc | $2.98B | - | +34.5% | - | |
IMNM | Immunome Inc | $2.91B | - | -63.3% | - | |
BEAM | Beam Therapeutics Inc | $2.83B | - | +158.9% | - | |
KOD | Kodiak Sciences Inc | $2.72B | - | - | - |
Top Peer by Growth
Beam Therapeutics Inc
+158.9% YoY Revenue
Lowest P/E Ratio
Arcutis Biotherapeutics Inc
113.86x P/E
Best 1-Year Return
Kodiak Sciences Inc
+363.8% Return